HK1235010B - Topical composition for skin - Google Patents
Topical composition for skin Download PDFInfo
- Publication number
- HK1235010B HK1235010B HK17108804.0A HK17108804A HK1235010B HK 1235010 B HK1235010 B HK 1235010B HK 17108804 A HK17108804 A HK 17108804A HK 1235010 B HK1235010 B HK 1235010B
- Authority
- HK
- Hong Kong
- Prior art keywords
- carbon atoms
- chemical formula
- meth
- alkyl group
- monomer
- Prior art date
Links
Description
技术领域Technical Field
本申请涉及皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物。The present application relates to a skin external application composition, a cosmetic composition, or a mascara composition.
背景技术Background Art
在化妆品或医药用品等的制备中有时需要功能高分子。例如,在化妆品(例如,睫毛膏等)或其他适用于皮肤的化妆品或医药用品中,可能需要对不同属性的溶剂(例如,汗液、泪液和皮脂等)具有耐性的高分子。专利文献1和2中记载了适用于化妆品的制备的高分子。Functional polymers are sometimes required in the preparation of cosmetics or pharmaceuticals. For example, cosmetics (e.g., mascara) or other cosmetics or pharmaceuticals applied to the skin may require polymers that are resistant to solvents of varying properties (e.g., sweat, tears, and sebum). Patent Documents 1 and 2 describe polymers suitable for the preparation of cosmetics.
现有技术文献Prior art literature
专利文献Patent Literature
专利文献1:日本特许公开第2000-119140号Patent Document 1: Japanese Patent Publication No. 2000-119140
专利文献2:日本特许公开第2003-055136号Patent Document 2: Japanese Patent Publication No. 2003-055136
发明内容Summary of the Invention
发明所要解决的问题Problems to be solved by the invention
本申请提供皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物。本申请的一个主要目的在于,提供一种皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物,其包含对极性和非极性溶剂表现出低溶解度、能够防止对上述溶剂扩散的、适合成膜的功能高分子。The present application provides a composition for external use on the skin, a cosmetic composition, or a mascara composition. A primary object of the present application is to provide a composition for external use on the skin, a cosmetic composition, or a mascara composition comprising a functional polymer that exhibits low solubility in polar and non-polar solvents, prevents diffusion into these solvents, and is suitable for film formation.
解决问题的技术方案Technical solutions to the problem
本申请的皮肤外用剂组合物可包含后述高分子。上述皮肤外用剂组合物例如可被剂型化为例如如睫毛膏组合物那样的化妆材料组合物。在这种情况下,上述组合物可含有化妆品学或皮肤科学上可允许的介质或基质而被剂型化。The skin topical composition of the present application may contain a polymer described below. The skin topical composition may be formulated into a cosmetic composition, such as a mascara composition. In this case, the composition may be formulated with a medium or base acceptable in cosmetics or dermatology.
本申请的皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物的剂型不受特别限制,可根据目的形成多种剂型。例如,上述剂型可适当地选自粉末剂、凝胶剂、软膏剂、霜剂或溶液剂等。例如,上述皮肤外用剂组合物可制备成柔软化妆水、营养化妆水、营养霜、按摩霜、精华素、泡沫、面膜、乳液、粉底霜、化妆底霜、凝胶、润肤液、肥皂、液体清洗剂、沐浴露、防晒霜、防晒油、喷射型溶液剂、软膏、膏剂或喷雾剂等剂型。The dosage form of the skin external application composition, cosmetic material composition or mascara composition of the present application is not particularly limited and can be formed into a variety of dosage forms according to the purpose. For example, the above dosage form can be appropriately selected from powders, gels, ointments, creams or solutions. For example, the above skin external application composition can be prepared into dosage forms such as softening lotions, nourishing lotions, nourishing creams, massage creams, essences, foams, facial masks, lotions, foundation creams, makeup bases, gels, lotions, soaps, liquid detergents, shower gels, sunscreens, sunscreen oils, spray-type solutions, ointments, pastes or sprays.
在一个例示中,上述皮肤外用剂组合物可适用于同时产生皮脂和汗液的生发部位、例如诸如眉毛、头发或腋下等同时需要耐水性和耐油性的皮肤部位,作为其一例,可举出睫毛膏组合物,但不限于此。In one example, the above-mentioned skin external application composition can be applied to hair-producing areas where sebum and sweat are produced simultaneously, such as eyebrows, hair, or underarms, and other skin areas that require both water resistance and oil resistance. As an example, a mascara composition can be mentioned, but it is not limited to this.
例如,上述睫毛膏组合物可包含后述高分子作为成膜剂。在这种情况下,通过上述高分子,能够防止泪液或汗液等导致的睫毛膏组合物的扩散,还能够防止皮脂导致的化妆扩散等。For example, the mascara composition may contain a polymer described below as a film-forming agent. In this case, the polymer can prevent the mascara composition from spreading due to tears or sweat, and can also prevent makeup from spreading due to sebum.
下面,对上述皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物中包含的高分子进行说明。Next, the polymer contained in the above-mentioned external skin preparation composition, cosmetic composition, or mascara composition will be described.
本申请的高分子如后述那样,可对极性溶剂和非极性溶剂均可表现出低溶解度或者具有规定范围的玻璃化转变温度,根据情况可全部具有上述特性。As described later, the polymer of the present application may exhibit low solubility in both polar and non-polar solvents or have a glass transition temperature within a predetermined range, and may have all of the above characteristics in some cases.
本申请的高分子可对极性溶剂和非极性溶剂可表现出低溶解度。本申请中,术语非极性溶剂表示25℃下的介电常数(dielectric constant)在约1至3、约1.5至2.5或约1.5至2左右的范围内的溶剂,术语极性溶剂可表示25℃下的介电常数(dielectric constant)在约75至85或约75至80的范围内的溶剂。作为上述非极性溶剂的代表性例子,可举出己烷(介电常数(25℃):约1.89),作为上述极性溶剂的代表性例子,可举出水(介电常数(25℃):约78.54),但不限于此。化学领域中,介电常数对每种溶剂是已知的。The polymer of the present application may exhibit low solubility in polar solvents and non-polar solvents. In the present application, the term non-polar solvent refers to a solvent having a dielectric constant (dielectric constant) at 25°C in the range of about 1 to 3, about 1.5 to 2.5, or about 1.5 to 2, and the term polar solvent may refer to a solvent having a dielectric constant (dielectric constant) at 25°C in the range of about 75 to 85 or about 75 to 80. As a representative example of the above-mentioned non-polar solvent, hexane (dielectric constant (25°C): about 1.89) can be cited, and as a representative example of the above-mentioned polar solvent, water (dielectric constant (25°C): about 78.54) can be cited, but are not limited thereto. In the field of chemistry, the dielectric constant is known for each solvent.
在一个例示中,上述高分子对上述极性溶剂的溶解度可为10以下或5以下。在一个例示中,上述高分子对上述非极性溶剂的溶解度可为10以下或5以下。上述溶解度表示其数值越低,上述高分子对该溶剂的耐性越优异,因此对其下限没有特别限制。本申请中,对特定溶剂的溶解度表示对该溶剂100g最大限度能够溶解的高分子的克数(g)。另外,若无特别规定,则本申请中的溶解度表示常温下测得的溶解度。本申请中,术语常温为不被加温或减温的自然状态的温度,例如可以是约10℃至30℃、约15℃至30℃或约20℃至30℃的范围内的温度,或者约25℃左右的温度。In one example, the solubility of the polymer in the polar solvent may be less than 10 or less than 5. In one example, the solubility of the polymer in the non-polar solvent may be less than 10 or less than 5. The solubility indicates that the lower the value is, the better the resistance of the polymer to the solvent is, so there is no particular restriction on its lower limit. In the present application, the solubility in a specific solvent indicates the number of grams (g) of the polymer that can be dissolved in 100g of the solvent to the maximum extent. In addition, unless otherwise specified, the solubility in the present application indicates the solubility measured at room temperature. In the present application, the term normal temperature refers to the temperature in the natural state without being heated or cooled, for example, it can be a temperature in the range of about 10°C to 30°C, about 15°C to 30°C or about 20°C to 30°C, or a temperature of about 25°C.
上述高分子可对处于上述极性和非极性溶剂的中间阶段的溶剂表现出合适的溶解度。例如,上述高分子对25℃下的介电常数(dielectric constant)在4至15、5至15、5至10或5至8的范围内的溶剂的溶解度可在15以上或约15至50的范围内。作为这种溶剂,可例示出:乙酸乙酯(介电常数(25℃):约6.02)等,但不限于此。The polymer may exhibit suitable solubility in solvents intermediate between the polar and non-polar solvents. For example, the polymer may have a solubility of 15 or greater, or approximately 15 to 50, in solvents having a dielectric constant at 25°C ranging from 4 to 15, 5 to 15, 5 to 10, or 5 to 8. Examples of such solvents include, but are not limited to, ethyl acetate (dielectric constant (25°C): approximately 6.02).
本申请的高分子的玻璃化转变温度可以为10℃以上。上述玻璃化转变温度在另一例示中可以为15℃以上、20℃以上、25℃以上或30℃以上。高分子的玻璃化转变温度可以为约110℃以下、约100℃以下、90℃以下、80℃以下、70℃、60℃以下或55℃以下。本申请中,玻璃化转变温度为通过所谓的福克斯方程式(Fox equation)从高分子的单体组成求出的理论数值。如上述那样的玻璃化转变温度例如可对上述高分子被用作成膜剂的情况有用。在上述玻璃化转变温度的范围内,可使用上述高分子有效地形成覆膜而无发粘或破碎现象等。The glass transition temperature of the polymer of the present application may be 10°C or more. In another example, the glass transition temperature may be 15°C or more, 20°C or more, 25°C or more, or 30°C or more. The glass transition temperature of the polymer may be about 110°C or less, about 100°C or less, 90°C or less, 80°C or less, 70°C or less, 60°C or less, or 55°C or less. In the present application, the glass transition temperature is a theoretical value obtained from the monomer composition of the polymer by the so-called Fox equation. The glass transition temperature as described above may be useful, for example, in the case where the above-mentioned polymer is used as a film-forming agent. Within the range of the above-mentioned glass transition temperature, the above-mentioned polymer can be used to effectively form a coating without stickiness or breakage, etc.
如上述那种特性的高分子可通过例如调节形成上述高分子的单体的种类及其比率来制备。A polymer having the above-mentioned characteristics can be prepared by, for example, adjusting the types and ratios of monomers forming the polymer.
例如,上述高分子可包含均聚物的溶解度参数小于10(cal/cm3)1/2的第一单体聚合单元以及均聚物的溶解度参数为10(cal/cm3)1/2以上的第二单体聚合单元。For example, the polymer may include a first monomer unit having a homopolymer solubility parameter of less than 10 (cal/cm 3 ) 1/2 and a second monomer unit having a homopolymer solubility parameter of 10 (cal/cm 3 ) 1/2 or more.
本申请中,溶解度参数表示将相应单体聚合而制得的均聚物(homopolymer)的溶解度参数,由此可掌握该单体的亲水性和疏水性的程度。对求出溶解度参数的方式没有特别限制,可根据本领域中公知的方式。例如,上述参数可根据本领域已知的所谓HSP(Hansen溶度参数(Hansen solubility parameter))的方式来计算或求出。上述中,在另一实施例中,第一单体的均聚物的溶解度参数可在5(cal/cm3)1/2至9.5(cal/cm3)1/2或7(cal/cm3)1/2至9(cal/cm3)1/2左右的范围内。另外,上述中,第二单体的溶解度参数在另一例示中,可在10(cal/cm3)1/2至15(cal/cm3)1/2或10(cal/cm3)1/2至13(cal/cm3)1/2的范围内。可适当地使用具有如上范围的溶解度参数的单体能够形成表现前述特性的高分子。In the present application, the solubility parameter refers to the solubility parameter of a homopolymer obtained by polymerizing the corresponding monomer, thereby understanding the degree of hydrophilicity and hydrophobicity of the monomer. There is no particular limitation on the method for determining the solubility parameter, and methods known in the art can be used. For example, the above parameter can be calculated or determined using the so-called HSP (Hansen solubility parameter) method known in the art. In the above, in another embodiment, the solubility parameter of the homopolymer of the first monomer can be in the range of about 5 (cal/cm 3 ) 1/2 to 9.5 (cal/cm 3 ) 1/2 or 7 (cal/cm 3 ) 1/2 to 9 (cal/cm 3 ) 1/2 . In the above, the solubility parameter of the second monomer can be, in another example, in the range of 10 (cal/cm 3 ) 1/2 to 15 (cal/cm 3 ) 1/2 or 10 (cal/cm 3 ) 1/2 to 13 (cal/cm 3 ) 1/2 . Suitable use of monomers having solubility parameters in the above ranges can form polymers exhibiting the aforementioned properties.
另外,本申请中,任何单体或化合物的聚合单元表示该单体或化合物经由聚合反应而以单体单元包含在高分子中的形态。In the present application, a polymerized unit of any monomer or compound means a form in which the monomer or compound is contained in a polymer as a monomer unit through a polymerization reaction.
作为第一单体,只要具有上述溶解度参数,就可以选择多种单体来使用。作为能够用作第一单体的单体,可例示出:(甲基)丙烯酸烷基酯或芳香族(甲基)丙烯酸酯。本申请中,术语(甲基)丙烯酸酯可表示丙烯酸酯或甲基丙烯酸酯。As the first monomer, a variety of monomers can be selected as long as they have the above-mentioned solubility parameters. Examples of monomers that can be used as the first monomer include alkyl (meth)acrylates and aromatic (meth)acrylates. In this application, the term (meth)acrylate can refer to either acrylate or methacrylate.
作为包含在上述(甲基)丙烯酸烷基酯的烷基,可例示出:碳数1至20、碳数4至20、碳数8至20或碳数10至20的直链、支链或环状的烷基,上述烷基能够被任一种以上的取代基取代。作为这种单体,可例示出:(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸正丙酯、(甲基)丙烯酸异丙酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸叔丁酯、(甲基)丙烯酸仲丁酯、(甲基)丙烯酸戊酯、(甲基)丙烯酸2-乙基己酯、(甲基)丙烯酸2-乙基丁酯、(甲基)丙烯酸正辛酯、(甲基)丙烯酸异冰片酯、(甲基)丙烯酸异辛酯、(甲基)丙烯酸异壬酯或(甲基)丙烯酸十二烷基酯等,但不限于此。Examples of the alkyl group contained in the alkyl (meth)acrylate include linear, branched, or cyclic alkyl groups having 1 to 20 carbon atoms, 4 to 20 carbon atoms, 8 to 20 carbon atoms, or 10 to 20 carbon atoms. These alkyl groups may be substituted with one or more substituents. Examples of such monomers include, but are not limited to, methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, tert-butyl (meth)acrylate, sec-butyl (meth)acrylate, amyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, 2-ethylbutyl (meth)acrylate, n-octyl (meth)acrylate, isobornyl (meth)acrylate, isooctyl (meth)acrylate, isononyl (meth)acrylate, and dodecyl (meth)acrylate.
作为上述芳香族(甲基)丙烯酸酯,可例示出:(甲基)丙烯酸芳基酯或(甲基)丙烯酸芳基烷基酯。上述中,芳基或芳基烷基的芳基例如可以是碳数6至24、碳数6至18或碳数6至12的芳基。另外,上述芳基烷基的烷基例如可以是碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的烷基。上述中,烷基可为直链、支链或环状,且上述烷基或芳基可被任一种以上的取代基取代。Examples of the aromatic (meth)acrylate include aryl (meth)acrylates and arylalkyl (meth)acrylates. In the above examples, the aryl group or the aryl group of the arylalkyl group may be, for example, an aryl group having 6 to 24 carbon atoms, 6 to 18 carbon atoms, or 6 to 12 carbon atoms. Furthermore, the alkyl group of the arylalkyl group may be, for example, an alkyl group having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms. In the above examples, the alkyl group may be linear, branched, or cyclic, and the alkyl or aryl group may be substituted with one or more substituents.
作为上述芳基或芳基烷基,可例示出:苯基、苯乙基、苯丙基或萘基等,但不限于此。Examples of the aryl group or arylalkyl group include, but are not limited to, a phenyl group, a phenethyl group, a phenylpropyl group, and a naphthyl group.
作为第一单体,例如可例示出由以下化学式1所示的化合物。As the first monomer, for example, a compound represented by the following Chemical Formula 1 can be exemplified.
[化学式1][Chemical Formula 1]
化学式1中,Q可为氢或烷基,B可为碳数4以上的直链或支链烷基或脂环族烃基或者为上述芳基或芳基烷基等芳香族取代基。In Chemical Formula 1, Q may be hydrogen or an alkyl group, and B may be a linear or branched alkyl group or an alicyclic hydrocarbon group having 4 or more carbon atoms, or an aromatic substituent such as the above-mentioned aryl group or arylalkyl group.
化学式1中,作为存在于Q中的烷基,可例示出碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的烷基。上述烷基可为直链、支链或环状。上述烷基可被任一种以上的取代基取代。In Chemical Formula 1, examples of the alkyl group present in Q include an alkyl group having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms. The alkyl group may be linear, branched, or cyclic. The alkyl group may be substituted with any one or more substituents.
化学式1中,B可为碳数4以上、碳数7以上或碳数9以上的直链或支链烷基。如此,包含相对长链烷基的化合物被称为疏水化合物。对上述直链或支链烷基的碳数的上限没有特别限制,例如,上述烷基可为碳数20以下的烷基。In Chemical Formula 1, B can be a linear or branched alkyl group having 4 or more carbon atoms, 7 or more carbon atoms, or 9 or more carbon atoms. Compounds containing relatively long-chain alkyl groups are referred to as hydrophobic compounds. There is no particular upper limit on the number of carbon atoms in the linear or branched alkyl group; for example, the alkyl group can have 20 or fewer carbon atoms.
在其他实施例中,化学式1中的B可为脂环族烃基、例如碳数3至20、碳数3至16或碳数6至12的脂环族烃基,作为这种烃基的例子,可例示出:诸如环己基或异冰片基等碳数3至20、碳数3至16或碳数6至12的脂环族烷基等。如此,具有脂环族烃基的化合物也被称为相对的疏水化合物。In other embodiments, B in Chemical Formula 1 may be an alicyclic hydrocarbon group, such as an alicyclic hydrocarbon group having 3 to 20 carbon atoms, 3 to 16 carbon atoms, or 6 to 12 carbon atoms. Examples of such hydrocarbon groups include alicyclic alkyl groups having 3 to 20 carbon atoms, 3 to 16 carbon atoms, or 6 to 12 carbon atoms, such as cyclohexyl or isobornyl. Compounds having alicyclic hydrocarbon groups are also referred to as relatively hydrophobic compounds.
本申请中,作为能够任意地取代于上述化学式1或后述化学式2或3中的烷基、亚烷基或芳香族取代基等上的取代基,可例示出氯或氟等卤基;缩水甘油基、环氧烷基、环氧丙氧基烷基或脂环族环氧基等环氧基;丙烯酰基、甲基丙烯酰、异氰酸酯基、巯基、烷基、烯基、炔基或芳基等,但不限于此。In the present application, examples of substituents that can be arbitrarily substituted on the alkyl, alkylene, or aromatic substituents in the above Chemical Formula 1 or the later-described Chemical Formula 2 or 3 include, but are not limited to, halogen groups such as chlorine or fluorine; epoxy groups such as glycidyl, epoxyalkyl, glycidoxyalkyl, or alicyclic epoxy groups; acryloyl, methacryloyl, isocyanate, mercapto, alkyl, alkenyl, alkynyl, or aryl groups.
可考虑目标高分子的物性,从如上述那样的单体中选择合适的种类来使用。Taking the physical properties of the target polymer into consideration, appropriate types can be selected from the monomers described above and used.
作为第二单体,也可使用选自已知具有前述溶解度参数的单体中的单体。As the second monomer, a monomer selected from monomers known to have the aforementioned solubility parameters can also be used.
例如,作为第二单体,可使用由以下化学式2或3所示的化合物。For example, as the second monomer, a compound represented by the following Chemical Formula 2 or 3 may be used.
[化学式2][Chemical Formula 2]
化学式2中,Q为氢或烷基,U为亚烷基,Z为氢或烷基,m为任意数;In Chemical Formula 2, Q is hydrogen or an alkyl group, U is an alkylene group, Z is hydrogen or an alkyl group, and m is any number;
[化学式3][Chemical Formula 3]
化学式3中,Q为氢或烷基,A和U各自独立地为亚烷基,X为羟基或氰基。In Chemical Formula 3, Q is hydrogen or an alkyl group, A and U are each independently an alkylene group, and X is a hydroxyl group or a cyano group.
化学式2和3中,作为亚烷基,可例示出碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的亚烷基。上述亚烷基可为直链、支链或环状。上述亚烷基可任意地取代有一个以上的取代基。In Chemical Formulas 2 and 3, examples of the alkylene group include an alkylene group having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms. These alkylene groups may be linear, branched, or cyclic. These alkylene groups may be optionally substituted with one or more substituents.
化学式2和3中,作为存在于Q和Z的烷基,可例示出碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的烷基。上述烷基可为直链、支链或环状。另外,上述烷基可任意地取代有一个以上的取代基。In Chemical Formulas 2 and 3, examples of the alkyl groups present in Q and Z include those having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms. These alkyl groups may be linear, branched, or cyclic. Furthermore, these alkyl groups may be optionally substituted with one or more substituents.
化学式2和3中,m和n为任意数,例如可各自独立地为1至100、1至90、1至80、1至70、1至60、1至50、1至40、1至30、1至20、1至16或1至12的范围内的数。In Chemical Formulas 2 and 3, m and n are arbitrary numbers, for example, each independently within the range of 1 to 100, 1 to 90, 1 to 80, 1 to 70, 1 to 60, 1 to 50, 1 to 40, 1 to 30, 1 to 20, 1 to 16, or 1 to 12.
在一个例示中,作为第二单体,可使用在上述化学式2中Q为氢或碳数1至4的烷基、U为碳数1至4的亚烷基、Z为氢或碳数1至4的烷基、m为1至30左右的化合物,但不限于此。In one example, as the second monomer, a compound in which Q in the above chemical formula 2 is hydrogen or an alkyl group with 1 to 4 carbon atoms, U is an alkylene group with 1 to 4 carbon atoms, Z is hydrogen or an alkyl group with 1 to 4 carbon atoms, and m is approximately 1 to 30 can be used, but is not limited thereto.
高分子可通过将上述第一单体和第二单体以适当比率聚合来制备。The polymer can be prepared by polymerizing the first monomer and the second monomer at an appropriate ratio.
例如,上述高分子可包含第一单体聚合单元50至99.9重量份和第二单体聚合单元0.1至20重量份。上述中,在另一个例示中,第一单体聚合单元可以60至99.9重量份、70至99.9重量份或80至99.9重量份存在。另外,第二单体聚合单元可以5至20重量份或7至20重量份包含在内。本申请中,若无特别规定,则单位重量份可表示各成分间的重量的比率。另外,上述中,单体的聚合单元的重量比率可表示在制备上述高分子时所使用的单体的重量比率。由此,例如,上述高分子包含第一单体聚合单元50至99.9重量份和第二单体聚合单元0.1至20重量份可表示,以50至99.9:0.1至20的重量比率(第一单体:第二单体)包含第一单体和第二单体的单体混合物聚合而形成上述高分子的情况。高分子中,第二单体的重量比率小于0.1重量份或者第一单体的重量比率大于99.9重量份时,对油性溶剂的耐性或耐皮脂性有可能不充分,第二单体的重量比率大于20重量份或者第一单体的重量比率小于50重量份时,因相分离等有可能无法形成高分子或者对极性溶剂的耐性或对汗液或泪液等的耐性有可能不充分。For example, the polymer may comprise 50 to 99.9 parts by weight of a first monomer unit and 0.1 to 20 parts by weight of a second monomer unit. In the above, in another example, the first monomer unit may be present in 60 to 99.9 parts by weight, 70 to 99.9 parts by weight, or 80 to 99.9 parts by weight. In addition, the second monomer unit may be included in 5 to 20 parts by weight or 7 to 20 parts by weight. In this application, unless otherwise specified, the unit weight part may represent the weight ratio between the components. In addition, in the above, the weight ratio of the monomer units may represent the weight ratio of the monomers used in the preparation of the polymer. Thus, for example, the polymer comprising 50 to 99.9 parts by weight of a first monomer unit and 0.1 to 20 parts by weight of a second monomer unit may represent the case where the polymer is formed by polymerizing a monomer mixture containing the first monomer and the second monomer in a weight ratio of 50 to 99.9:0.1 to 20 (first monomer: second monomer). If the weight ratio of the second monomer in the polymer is less than 0.1 parts by weight or the weight ratio of the first monomer is greater than 99.9 parts by weight, resistance to oily solvents or sebum may be insufficient. If the weight ratio of the second monomer is greater than 20 parts by weight or the weight ratio of the first monomer is less than 50 parts by weight, the polymer may not be formed due to phase separation, or resistance to polar solvents or resistance to sweat, tears, etc. may be insufficient.
在另一例示中,上述高分子以重量为基准计,可包含50%以上、55%以上、60%以上、65%以上、70%以上、75%以上或80%以上的上述第一单体聚合单元。上述第一单体聚合单元的比率以重量为基准计可以为99%以下、98%以下、97%以下、96%以下、95%以下、94%以下、93%以下、92%以下、91%以下或90%以下。在如上述那样的状态下,上述高分子可相对于上述第一单体聚合单元100重量份,以40重量份以下、35重量份以下、30重量份以下、25重量份以下、20重量份以下、15重量份以下、10重量份以下或约8重量份以下的比率包含上述第二单体聚合单元。上述第二单体聚合单元可以以相对于上述第一单体聚合单元100重量份为约0.1重量份以上、0.15重量份以上、0.2重量份以上或5重量份以上的比率包含在上述高分子中。上述比率中,能够确保对油性溶剂的耐性或耐皮脂性,并且还能够有效地确保对极性溶剂的耐性或对汗液或泪液等的耐性。In another example, the polymer may contain 50% or more, 55% or more, 60% or more, 65% or more, 70% or more, 75% or more, or 80% or more of the polymerized units of the first monomer, based on weight. The ratio of the polymerized units of the first monomer, based on weight, may be 99% or less, 98% or less, 97% or less, 96% or less, 95% or less, 94% or less, 93% or less, 92% or less, 91% or less, or 90% or less. In such a state, the polymer may contain the polymerized units of the second monomer at a ratio of 40 parts by weight or less, 35 parts by weight or less, 30 parts by weight or less, 25 parts by weight or less, 20 parts by weight or less, 15 parts by weight or less, 10 parts by weight or less, or about 8 parts by weight or less, per 100 parts by weight of the polymerized units of the first monomer. The second monomeric polymerized units may be included in the polymer at a ratio of approximately 0.1 parts by weight or greater, 0.15 parts by weight or greater, 0.2 parts by weight or greater, or 5 parts by weight or greater, relative to 100 parts by weight of the first monomeric polymerized units. These ratios ensure resistance to oily solvents or sebum, and also effectively ensure resistance to polar solvents or resistance to sweat, tears, and the like.
除前述第一单体和第二单体以外,高分子还可以包含其他追加的单体。In addition to the aforementioned first monomer and second monomer, the polymer may further contain other additional monomers.
例如,上述高分子可包含作为含硅原子的化合物、例如下述化学式5的化合物作为聚合单元。下述化学式5的化合物可在高分子内形成硅氧烷键,这种硅氧烷键对高分子的聚集性改善产生影响,能够有助于改善耐水性和耐油性。For example, the polymer may include a silicon-containing compound, such as the compound represented by the following chemical formula 5, as a polymer unit. The compound represented by the following chemical formula 5 can form siloxane bonds within the polymer, which improves the polymer's cohesiveness and contributes to improved water resistance and oil resistance.
[化学式5][Chemical Formula 5]
化学式5中,R1至R6各自独立地为氢、羟基、烷基、烷氧基、烯基、(甲基)丙烯酰基、(甲基)丙烯酰基烷基、(甲基)丙烯酰氧基或(甲基)丙烯酰氧基烷基,至少一者为烯基、(甲基)丙烯酰基、(甲基)丙烯酰基烷基、(甲基)丙烯酰氧基或(甲基)丙烯酰氧基烷基。In Chemical Formula 5, R1 to R6 are each independently hydrogen, hydroxyl, alkyl, alkoxy, alkenyl, (meth)acryloyl, (meth)acryloylalkyl, (meth)acryloyloxy, or (meth)acryloyloxyalkyl, and at least one is alkenyl, (meth)acryloyl, (meth)acryloylalkyl, (meth)acryloyloxy, or (meth)acryloyloxyalkyl.
另外,化学式5中,n为0至20的范围内的数。In addition, in Chemical Formula 5, n is a number within the range of 0 to 20.
化学式5中,作为烷基或烷氧基,可例示出碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的直链、支链或环状烷基或烷氧基,其可任意地取代有一个以上的取代基。In Chemical Formula 5, examples of the alkyl group or alkoxy group include linear, branched, or cyclic alkyl groups or alkoxy groups having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms, which may be arbitrarily substituted with one or more substituents.
化学式5中,作为烯基,可例示出碳数2至20、碳数2至16、碳数2至12、碳数2至8或碳数2至4的直链、支链或环状烯基,其可任意地取代有一个以上的取代基。In Chemical Formula 5, examples of the alkenyl group include linear, branched, or cyclic alkenyl groups having 2 to 20 carbon atoms, 2 to 16 carbon atoms, 2 to 12 carbon atoms, 2 to 8 carbon atoms, or 2 to 4 carbon atoms, which may be arbitrarily substituted with one or more substituents.
化学式5中,R1至R6中的至少一者为如烯基、(甲基)丙烯酰基、(甲基)丙烯酰基烷基、(甲基)丙烯酰氧基或(甲基)丙烯酰氧基烷基等那样的聚合性官能团,通过这种官能团,上述化合物可作为聚合单元包含在上述高分子中。上述聚合性官能团通常可以是(甲基)丙烯酰基烷基或(甲基)丙烯酰氧基烷基,上述中,烷基如前述那样可以是碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的取代或非取代的直链、支链或环状的烷基。In Chemical Formula 5, at least one of R1 to R6 is a polymerizable functional group such as an alkenyl group, a (meth)acryloyl group, a (meth)acryloylalkyl group, a (meth)acryloyloxy group, or a (meth)acryloyloxyalkyl group. Through this functional group, the compound can be included as a polymerized unit in the polymer. The polymerizable functional group is typically a (meth)acryloylalkyl group or a (meth)acryloyloxyalkyl group. As described above, the alkyl group can be a substituted or unsubstituted linear, branched, or cyclic alkyl group having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms.
化学式5中,R1至R6中的至少一者、2个以上或3个可以是烷氧基。In Chemical Formula 5, at least one, two or more, or three of R1 to R6 may be an alkoxy group.
在一个例示中,化学式5的化合物可以是如下的化合物:上述化学式5中,n为0,R1、R3、R5和R6各自独立地为氢、烷基、烷氧基、(甲基)丙烯酰基烷基或(甲基)丙烯酰氧基烷基,且R1、R3、R5和R6中的至少一者、2个以上或3个为烷氧基,R1、R3、R5和R6中的至少一者为(甲基)丙烯酰基烷基或(甲基)丙烯酰氧基烷基。在这种情况下,上述烷基可以是碳数1至8的烷基,烷氧基可以是碳数1至8的烷氧基。In one example, the compound of Chemical Formula 5 may be the following: In Chemical Formula 5, n is 0, R1, R3, R5, and R6 are each independently hydrogen, an alkyl group, an alkoxy group, a (meth)acryloylalkyl group, or a (meth)acryloyloxyalkyl group, and at least one, two or more, or three of R1, R3, R5, and R6 are alkoxy groups, and at least one of R1, R3, R5, and R6 is a (meth)acryloylalkyl group or a (meth)acryloyloxyalkyl group. In this case, the alkyl group may be an alkyl group having 1 to 8 carbon atoms, and the alkoxy group may be an alkoxy group having 1 to 8 carbon atoms.
在另一个例示中,化学式5的化合物可以是如下的化合物:上述化学式5中,n为1以上,R1至R6各自独立地为氢、烷基、烷氧基、(甲基)丙烯酰基烷基或(甲基)丙烯酰氧基烷基,且R1至R6中的至少一者为(甲基)丙烯酰基烷基或(甲基)丙烯酰氧基烷基。在这种情况下,R1至R6中,非(甲基)丙烯酰基烷基或(甲基)丙烯酰氧基烷基的官能团可以是烷基。上述中,烷基可以是碳数1至8的烷基、烷氧基可以是碳数1至8的烷氧基。In another example, the compound of Chemical Formula 5 may be the following: In the above Chemical Formula 5, n is 1 or greater, R1 to R6 are each independently hydrogen, an alkyl group, an alkoxy group, a (meth)acryloylalkyl group, or a (meth)acryloyloxyalkyl group, and at least one of R1 to R6 is a (meth)acryloylalkyl group or a (meth)acryloyloxyalkyl group. In this case, among R1 to R6, the functional group other than a (meth)acryloylalkyl group or a (meth)acryloyloxyalkyl group may be an alkyl group. In the above, the alkyl group may be an alkyl group having 1 to 8 carbon atoms, and the alkoxy group may be an alkoxy group having 1 to 8 carbon atoms.
高分子可包含上述第一单体聚合单元50至99.9重量份、第二单体聚合单元0.1至20重量份以及上述化学式5的化合物的聚合单元0.1至10重量份。上述中,若化学式5的化合物的聚合单元的比率过小,则因添加上述化合物带来的效果、例如赋予薄膜光泽或防止扩散的效果等有可能微弱,若过多,则高分子会表现出不适合成膜的物性。The polymer may include 50 to 99.9 parts by weight of polymerized units of the first monomer, 0.1 to 20 parts by weight of polymerized units of the second monomer, and 0.1 to 10 parts by weight of polymerized units of the compound of Chemical Formula 5. If the ratio of polymerized units of the compound of Chemical Formula 5 is too low, the effects of adding the compound, such as imparting gloss to the film or preventing diffusion, may be weak. If the ratio is too high, the polymer may exhibit properties unsuitable for film formation.
在另一例示中,上述高分子以重量为基准计可包含50%以上、55%以上、60%以上、65%以上、70%以上、75%以上或80%以上的上述第一单体聚合单元。上述第一单体聚合单元的比率以重量为基准计可以是99%以下、98%以下、97%以下、96%以下、95%以下、94%以下、93%以下、92%以下、91%以下或90%以下。在如上述那样的状态下,上述高分子相对于上述第一单体聚合单元100重量份可以以20重量份以下、15重量份以下、13重量份以下、10重量份以下或约8重量份以下的比率包含上述化学式5的化合物的聚合单元。上述化学式5的化合物的聚合单元相对于上述第一单体聚合单元100重量份可以以约0.1重量份以上、0.15重量份以上、0.2重量份以上、约0.5重量份以上或约1重量份以上的比率包含在上述高分子中。上述比率中,能够确保对油性溶剂的耐性或耐皮脂性,并且能够有效地确保对极性溶剂的耐性或对汗液或泪液等的耐性。In another example, the polymer may contain 50% or more, 55% or more, 60% or more, 65% or more, 70% or more, 75% or more, or 80% or more of the first monomer polymerized units, based on weight. The ratio of the first monomer polymerized units, based on weight, may be 99% or less, 98% or less, 97% or less, 96% or less, 95% or less, 94% or less, 93% or less, 92% or less, 91% or less, or 90% or less. In the above state, the polymer may contain polymerized units of the compound of Chemical Formula 5 at a ratio of 20 parts by weight or less, 15 parts by weight or less, 13 parts by weight or less, 10 parts by weight or less, or about 8 parts by weight or less, relative to 100 parts by weight of the first monomer polymerized units. The polymerized units of the compound of Chemical Formula 5 may be included in the polymer at a ratio of about 0.1 parts by weight or more, 0.15 parts by weight or more, 0.2 parts by weight or more, about 0.5 parts by weight or more, or about 1 part by weight or more, relative to 100 parts by weight of the polymerized units of the first monomer. These ratios ensure resistance to oily solvents or sebum, and effectively ensure resistance to polar solvents or resistance to sweat, tears, and the like.
另外,高分子在前述第一单体和第二单体聚合单元的基础上,还可包含乙烯基系单体的聚合单元。这种乙烯基系单体在聚合过程中,可使上述亲水性和疏水性单体有效地聚合而不发生相分离等。In addition to the polymerized units of the first and second monomers, the polymer may further include polymerized units of a vinyl monomer. Such a vinyl monomer can effectively polymerize the hydrophilic and hydrophobic monomers without phase separation during polymerization.
乙烯基系单体只要能够发挥如上述那样的作用,就可以不受特别限制地选择并使用。The vinyl monomer can be selected and used without particular limitation as long as it can exhibit the above-mentioned functions.
作为这种单体,可例示出N-丙烯酰胺化合物等酰胺系单体、乙烯基酯化合物等酯系单体或乙烯醚化合物等醚系单体等。Examples of such monomers include amide monomers such as N-acrylamide compounds, ester monomers such as vinyl ester compounds, and ether monomers such as vinyl ether compounds.
例如,作为上述乙烯基系单体,可使用下述化学式6的化合物。For example, as the vinyl monomer, a compound represented by the following Chemical Formula 6 may be used.
[化学式6][Chemical Formula 6]
化学式6中,X为氮原子或氧原子,Y为羰基或单键,R1和R3各自独立地为氢或烷基或者R1与R3一起连结而形成亚烷基,R2为烯基(其中,在X为氧原子的情况下,不存在R1)。In Chemical Formula 6, X is a nitrogen atom or an oxygen atom, Y is a carbonyl group or a single bond, R1 and R3 are each independently hydrogen or an alkyl group, or R1 and R3 are linked together to form an alkylene group, and R2 is an alkenyl group (wherein, when X is an oxygen atom, R1 is not present).
化学式6中,在Y为单键的情况下,在以Y表示的部分不存在其他原子,可体现R3与X直接连结而成的结构。In Chemical Formula 6, when Y is a single bond, no other atoms exist in the portion represented by Y, and a structure in which R3 and X are directly linked can be realized.
化学式6中,R2可例如为碳数2至20、碳数2至16、碳数2至12、碳数2至8或碳数2至4的直链、支链或环状的烯基,其可以为任意被取代或非取代的状态。通常,作为上述烯基,可使用乙烯基或烯丙基等。In Chemical Formula 6, R2 can be, for example, a linear, branched, or cyclic alkenyl group having 2 to 20 carbon atoms, 2 to 16 carbon atoms, 2 to 12 carbon atoms, 2 to 8 carbon atoms, or 2 to 4 carbon atoms, and can be substituted or unsubstituted. Typically, the alkenyl group can be a vinyl group or an allyl group.
化学式6中,R1和R3各自独立地为氢或碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的直链、支链或环状的烷基,或者可一起连结而形成碳数1至20、碳数2至16、碳数2至12或碳数2至8的亚烷基。上述中,在R1和R3形成亚烷基的情况下,化学式6的化合物可以是环状化合物。In Chemical Formula 6, R1 and R3 are each independently hydrogen or a linear, branched, or cyclic alkyl group having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms, or may be linked together to form an alkylene group having 1 to 20 carbon atoms, 2 to 16 carbon atoms, 2 to 12 carbon atoms, or 2 to 8 carbon atoms. In the above, when R1 and R3 form an alkylene group, the compound of Chemical Formula 6 may be a cyclic compound.
作为乙烯基系单体,可以使用例如:上述化学式6中的X为氮原子,Y为羰基,R1和R3各自独立地为氢或碳数1至20、碳数1至16、碳数1至12、碳数1至8或碳数1至4的烷基、R2为碳数2至20、碳数2至16、碳数2至12或2至8的烯基的化合物;或者上述化学式6中的X为氮原子,Y为羰基,R1和R3彼此连结而形成碳数3至12的亚烷基,R2为碳数2至20、碳数2至16、碳数2至12或2至8的烯基的化合物。作为这种化合物,可例示出N-乙烯基吡咯烷酮,N-乙烯基己内酰胺,N-乙烯基乙酰胺或N-乙烯基-N-甲基乙酰胺等,但不限于此。As the vinyl monomer, for example, a compound in which X in the above Chemical Formula 6 is a nitrogen atom, Y is a carbonyl group, R1 and R3 are each independently hydrogen or an alkyl group having 1 to 20 carbon atoms, 1 to 16 carbon atoms, 1 to 12 carbon atoms, 1 to 8 carbon atoms, or 1 to 4 carbon atoms, and R2 is an alkenyl group having 2 to 20 carbon atoms, 2 to 16 carbon atoms, 2 to 12 carbon atoms, or 2 to 8 carbon atoms; or a compound in which X in the above Chemical Formula 6 is a nitrogen atom, Y is a carbonyl group, R1 and R3 are linked to form an alkylene group having 3 to 12 carbon atoms, and R2 is an alkenyl group having 2 to 20 carbon atoms, 2 to 16 carbon atoms, 2 to 12 carbon atoms, or 2 to 8 carbon atoms can be used. Examples of such compounds include, but are not limited to, N-vinylpyrrolidone, N-vinylcaprolactam, N-vinylacetamide, and N-vinyl-N-methylacetamide.
另外,作为乙烯基系单体,也可使用如下的化合物:上述化学式6中,X为氧原子,Y为单键或羰基,R3为碳数1至20的烷基,R2为碳数2至20、碳数2至16、碳数2至12或2至8的烯基。作为这种化合物,可例示出乙酸乙烯酯、癸酸乙烯酯(vinyl decanoate)、新壬酸乙烯酯(vinyl neononanoate)或戊酸乙烯酯(vinyl valerate)等,但不限于此。Alternatively, the following compounds may be used as vinyl monomers: In the above Chemical Formula 6, X is an oxygen atom, Y is a single bond or a carbonyl group, R3 is an alkyl group having 1 to 20 carbon atoms, and R2 is an alkenyl group having 2 to 20 carbon atoms, 2 to 16 carbon atoms, 2 to 12 carbon atoms, or 2 to 8 carbon atoms. Examples of such compounds include, but are not limited to, vinyl acetate, vinyl decanoate, vinyl neononanoate, and vinyl valerate.
高分子可包含上述第一单体聚合单元50至99.9重量份、第二单体聚合单元0.1至20重量份以及上述乙烯基系单体的聚合单元1至30重量份。将乙烯基系单体的比率调节为上述提及的范围,从而能够容易地制备目标物性的高分子,而没有相分离现象。The polymer may comprise 50 to 99.9 parts by weight of polymerized units of the first monomer, 0.1 to 20 parts by weight of polymerized units of the second monomer, and 1 to 30 parts by weight of polymerized units of the vinyl monomer. By adjusting the ratio of the vinyl monomer to the above-mentioned range, a polymer having target physical properties can be easily prepared without phase separation.
在另一例示中,上述高分子以重量为基准计可包含50%以上、55%以上、60%以上、65%以上、70%以上、75%以上或80%以上的上述第一单体聚合单元。上述第一单体聚合单元的比率以重量为基准计可以是99%以下、98%以下、97%以下、96%以下、95%以下、94%以下、93%以下、92%以下、91%以下或90%以下。在如上述那样的状态下,上述高分子相对于上述第一单体聚合单元100重量份可以以60重量份以下、50重量份以下、45重量份以下、约40重量份以下、约30重量份以下、约25重量份以下、约20重量份以下或约15重量份的比率包含上述乙烯基系单体的聚合单元。上述乙烯基系单体的聚合单元相对于上述第一单体聚合单元100重量份可以以约0.1重量份以上、0.5重量份以上、1重量份以上、约2重量份以上或约4重量份以上的比率包含在上述高分子中。可将乙烯基系单体的比率调节为上述提及的范围来容易地制备目标物性的高分子,而没有相分离现象。In another example, the polymer may contain 50% or more, 55% or more, 60% or more, 65% or more, 70% or more, 75% or more, or 80% or more of the polymerized units of the first monomer, based on weight. The ratio of the polymerized units of the first monomer may be 99% or less, 98% or less, 97% or less, 96% or less, 95% or less, 94% or less, 93% or less, 92% or less, 91% or less, or 90% or less, based on weight. In the above state, the polymer may contain polymerized units of the vinyl monomer at a ratio of 60 parts by weight or less, 50 parts by weight or less, 45 parts by weight or less, about 40 parts by weight or less, about 30 parts by weight or less, about 25 parts by weight or less, about 20 parts by weight or less, or about 15 parts by weight per 100 parts by weight of the polymerized units of the first monomer. The polymerized units of the vinyl monomer may be included in the polymer at a ratio of about 0.1 parts by weight or more, 0.5 parts by weight or more, 1 part by weight or more, about 2 parts by weight or more, or about 4 parts by weight or more relative to 100 parts by weight of the polymerized units of the first monomer. By adjusting the ratio of the vinyl monomer to the aforementioned range, a polymer having desired physical properties can be easily prepared without phase separation.
高分子可使用上述第一单体和第二单体以公知的聚合方式制得。在一个例示中,上述高分子可通过使用溶剂(例如,有机溶剂)的溶液聚合方式、例如自由基溶液聚合方式来制备。例如,在上述高分子被用于化妆品等接触人体的用途的情况下,在上述聚合过程中,作为溶剂,可选择使用对人体无害的溶剂。作为这种溶剂,可例示出异十二烷(isododecane)、异构烷烃或异十六烷等,但不限于此。The polymer can be prepared using the first monomer and the second monomer in a known polymerization method. In one example, the polymer can be prepared by a solution polymerization method using a solvent (e.g., an organic solvent), such as a free radical solution polymerization method. For example, when the polymer is used for applications such as cosmetics that contact the human body, a solvent that is harmless to the human body can be selected as a solvent during the polymerization process. Examples of such solvents include, but are not limited to, isododecane, isoparaffins, and isohexadecane.
在一个例示中,如上述那样的高分子的制备基本上在前述第一单体和第二单体的存在下进行,还可在前述乙烯基系单体的存在下进行。这种聚合可通过所谓溶液聚合方式来进行。In one example, the preparation of the polymer described above is basically carried out in the presence of the first monomer and the second monomer, and may also be carried out in the presence of the vinyl monomer. This polymerization can be carried out by so-called solution polymerization.
即,本申请的制备方法可包括使包含上述第一单体、上述第二单体及上述乙烯基系单体的单体混合物在溶剂中发生溶液聚合的过程。That is, the preparation method of the present application may include a process of subjecting a monomer mixture comprising the first monomer, the second monomer, and the vinyl monomer to solution polymerization in a solvent.
上述中,单体混合物中所包含的第一单体和第二单体或乙烯基系单体的具体种类如前所述。另外,若需要,上述单体混合物也可包含如上述化学式5的化合物那样的其他单体。这种单体的可在合适的自由基引发剂的存在下进行,对此时所使用的具体的引发剂的种类没有特别限制。In the above, the specific types of the first monomer and the second monomer or the vinyl monomer contained in the monomer mixture are as described above. In addition, if necessary, the monomer mixture may also contain other monomers such as the compound of Chemical Formula 5. Such monomers can be reacted in the presence of a suitable free radical initiator, and the specific type of initiator used in this case is not particularly limited.
另外,上述各单体的比率例如也可以与前述各聚合单元的比率部分同样地适用。In addition, the ratio of each monomer mentioned above can also be partially applied in the same manner as the ratio of each polymerized unit mentioned above, for example.
上述聚合可使用有机溶剂、例如介电常数(25℃)在1至3的范围内的溶剂来进行。通过使用这种溶剂,能够实现上述第一单体和第二单体混合物与乙烯基系单体的均匀的混合,从而能够有效地形成目标高分子,并提高聚合速率,还能够提高生产率。The polymerization can be carried out using an organic solvent, for example, a solvent having a dielectric constant (25° C.) in the range of 1 to 3. By using such a solvent, uniform mixing of the first and second monomer mixtures with the vinyl monomer can be achieved, thereby efficiently forming the target polymer, increasing the polymerization rate, and improving productivity.
对如上述那样的溶剂的具体的种类没有特别限制,例如可以使用液体石蜡、具体而言为如异十二烷(isodedecane)等那样的碳数8至14的液体石蜡。The specific type of the above-mentioned solvent is not particularly limited. For example, liquid paraffin, specifically liquid paraffin having 8 to 14 carbon atoms such as isodedecane, can be used.
对于上述制备方法,除前述事项、例如使用前述单体混合物等以外,可基于通常的溶液聚合方式来进行。如前所述,上述单体混合物包含出现相分离等的概率高的第一单体和第二单体,但由于存在乙烯基系单体,因此能够有效地进行聚合而形成高分子。The above-mentioned preparation method can be carried out according to a conventional solution polymerization method, except for the aforementioned matters, such as the use of the above-mentioned monomer mixture. As mentioned above, the above-mentioned monomer mixture contains a first monomer and a second monomer, which are likely to undergo phase separation, but the presence of the vinyl monomer allows efficient polymerization to form a polymer.
本申请中,上述高分子可在重均分子量(Mw)为10000至500000的范围内。本申请中,重均分子量例如可以是对使用GPC(凝胶渗透色谱仪,Gel Permeation Chromatograph)测定的标准聚苯乙烯的换算值,只要没有特别地另行规定,术语分子量可指代重均分子量。如上述那样的分子量(Mw)例如可对上述高分子被用作成膜剂的情况有用。在上述分子量(Mw)的范围内,可使用上述高分子有效地形成覆膜而无凝聚现象等。In the present application, the polymer may have a weight average molecular weight (Mw) in the range of 10,000 to 500,000. In the present application, the weight average molecular weight may be, for example, a conversion value to standard polystyrene measured using GPC (Gel Permeation Chromatograph), and the term molecular weight may refer to the weight average molecular weight unless otherwise specified. The molecular weight (Mw) as described above may be useful, for example, when the polymer is used as a film-forming agent. Within the range of the above molecular weight (Mw), the polymer can be used to effectively form a film without agglomeration, etc.
如上述那样的高分子例如可作为成膜剂(film former)使用。这种高分子可通过涂布等而形成均匀的膜(覆膜),且适用于皮肤等也表现出高稳定性,并对极性和非极性溶剂均显示出耐性,从而能够对如汗液、泪液或皮脂等多种溶剂表现出优异的耐性。Such polymers can be used, for example, as film formers. They can form uniform films (films) by coating, exhibit high stability even when applied to skin, and are resistant to both polar and non-polar solvents, demonstrating excellent resistance to a variety of solvents, including sweat, tears, and sebum.
由此,上述高分子可适用于成膜剂或化妆品用组合物的制备,该成膜剂或化妆品用组合物能够用于制备包括美容面膜、适用于嘴角或眼角等的睫毛膏等化装用品、可适用于手指甲或脚趾甲等的指甲油、口红、眼影、毛发用定型剂或眼线膏等在内的多种化妆品。另外,上述高分子或成膜剂等通过如上述那样的特性还可用作医药用途,作为医药用途,可例示出薄橡皮膏布或经皮吸收制剂等。Therefore, these polymers are suitable for use in the preparation of film-forming agents or cosmetic compositions. These film-forming agents or cosmetic compositions can be used to prepare a variety of cosmetics, including facial masks, makeup products such as mascara for use on the corners of the mouth and eyes, nail polish for use on fingernails and toenails, lipstick, eye shadow, hairspray, and eyeliner. Furthermore, due to the aforementioned properties, these polymers and film-forming agents can also be used in pharmaceuticals. Examples of pharmaceutical applications include thin adhesive plasters and transdermal absorption preparations.
在前述皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物中,对上述高分子的比率没有特别限制,可考虑适用用途等而进行选择。例如,高分子可以以约1重量%至20重量%的范围内的比率包含于上述皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物。The ratio of the polymer in the skin external application composition, cosmetic composition, or mascara composition is not particularly limited and can be selected in consideration of the intended use, etc. For example, the polymer can be contained in the skin external application composition, cosmetic composition, or mascara composition at a ratio ranging from approximately 1% to 20% by weight.
上述皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物根据用途还可包含其他有效成分。作为追加的有效成分,不仅可例示出如美白或抗紫外线等化妆品成分,还可例示出药用成分、生理活性成分或药理活性成分等。作为这样的有效成分,可例示出:局部麻醉成分(利多卡因、盐酸地布卡因、地布卡因、苯佐卡因等)、镇痛成分(水杨酸甲酯等水杨酸衍生物、吲哚美辛、吡罗昔康、酮洛芬、联苯乙酸等)、抗炎成分(甘草酸、甘草酸二钾等甘草酸盐类;甘草次酸、硬脂醇甘草亭酸酯、丁苯羟酸、烟酸苄酯、氢化可的松、丁酸氢化可的松、乙酸氢化可的松、强的松戊酸乙酸酯(prednisone valeroacetate)、乙酸强的松、强的松、地塞米松、乙酸地塞米松、二甲基异丙基甘菊环皮考布洛芬、山金车提取物、黄芩提取物、香蒲耳提取物、春黄菊提取物、炉甘石、甘草提取物、愈创兰油烃、桅子提取物、龙胆提取物、红茶提取物、生育酚、乙酸生育酚、紫草提取物、紫苏提取物、芍药提取物、鼠尾草提取物、日本獐牙菜提取物、桑白皮提取物、盐酸吡哆醇、桃叶提取物、矢车菊提取物、虎耳草提取物、艾蒿提取物、罗马洋甘菊提取物等)、抗组胺成分(马来酸氯苯那敏、苯海拉明、盐酸苯海拉明、水杨酸苯海拉明等)、局部刺激成分(氨、l-薄荷醇、dl-樟脑(dl-camphor)、薄荷油、烟酸苄酯、壬酸缬氨酰基酰胺等)、止痒成分(克罗他米通等)、防腐或杀菌成分(利凡诺(acrinol)、葡萄糖酸氯己定、盐酸氯己定、氯化苯甲烷铵、苄索氯铵、聚维酮碘、碘仿、碘、碘化钾、汞溴红、甲酚、三氯生、苯酚、异丙基甲酚、麝香草酚、水杨酸钠、十一烯酸、光敏剂、扁柏醇、苯氧乙醇、氯丁醇、季铵盐73、吡硫锌、对羟基苯甲酸酯类、桉树提取物、雷锁辛迷迭香等)、抗真菌成分(克霉唑、乙酸克霉唑、乙酸咪康唑、乙酸益康唑、联苯苄唑、乙酸氧康唑、乙酸硫康唑、盐酸奈康唑、联苯苄唑和噻康唑、乙酸奥莫康唑等咪唑系抗真菌剂类;特比萘芬、盐酸特比萘芬和萘替芬等烯丙胺系抗真菌剂类;布替萘芬等苄胺系抗真菌剂类;盐酸阿扑吗啡等烯丙胺系抗真菌剂类;托萘酯、托西拉酯等硫代氨基甲酸系抗真菌剂类;硝吡咯菌素、伊莎酰胺、环吡酮胺等)组织修复成分(尿囊素、肝素类似物、维生素A棕榈酸酯、维生素D2、视黄醇乙酸酯、视黄醇、维生素A油、泛醇等)、收敛成分(氧化锌、刺五加提取物、氯化铝、黄葫芦提取物及其盐、柠檬酸、白桦提取物、茶提取物、啤酒花提取物、马栗提取物等)、死皮增韧剂成分(尿素、甘油、浓缩甘油、氢氧化钾、水杨酸、硫、胶体硫、间苯二酚、甘醇酸、乳酸、硫酸钠等)、保湿成分(丁二醇、吡咯烷酮羧酸钠、丙二醇、核酸类钠盐、明日叶提取物、天冬氨酸、丙氨酸、精氨酸、藻酸钠、药属葵提取物、芦荟提取物、牡蛎提取物、水解角蛋白、水解胶原蛋白、水解贝壳硬蛋白、水解蛋壳膜、水解卵白、水解蚕丝、褐藻提取物、榅桲提取物、黑刺莓丛提取物、木糖醇、酮酸、黄瓜提取物、榅桲籽提取物、甘氨酸、甘油、葡萄糖、海角芦荟提取物、胱氨酸、半胱氨酸、锦葵提取物、丝氨酸、山梨糖醇、海藻酮糖、乳酸钠、透明质酸钠、胎盘提取物、丝瓜提取物、还原麦芽糖、甘露醇、百合提取物、乳铁蛋白、赖氨酸、苹果提取物、蜂王浆提取物等)、润肤剂成分(杏仁油、鳄梨油、橄榄油、油酸、大西洋胄胸鲷油(orange roughyoil)、可可脂、胡萝卜提取物、角鲨烯、神经酰胺、月见草油、葡萄籽油、霍霍巴油、澳洲坚果油、矿物油、貂油、桉树油、玫瑰果油、凡士林等)、增白成分(抗坏血酸、抗坏血酸衍生物、熊果苷、视黄醇(recinol)、鞣花酸、谷胱甘肽、曲酸、玫瑰果提取物、猕猴桃提取物等)、紫外线防护成分(对氨基苯甲酸、对氨基苯甲酸乙酯、对氨基苯甲酸甘油酯、对二甲基氨基苯甲酸戊醇酯、对二甲基氨基苯甲酸2-乙基己醇酯、叔丁基甲氧基二苯甲酰基甲烷、氧苯酮类、辛基三嗪酮、水杨酸辛酯、二异丙基肉桂酸乙酯、二异丙基肉桂酸甲酯、桂醚酯、二甲氧基肉桂酸甘油基辛酸酯、辛基二甲氧基亚苄基二氧代咪唑烷丙酸酯、茶叶提取物、甲酚曲唑、对甲氧基肉桂酸异丙酯、胡莫柳酯、甲氧基肉桂酸辛酯等)、草本提取物成分、维生素类、氨基酸类或矿物类等,但不限于此。The above-mentioned skin external preparation composition, cosmetic material composition or mascara composition may also contain other active ingredients according to the purpose. As additional active ingredients, not only cosmetic ingredients such as whitening or anti-ultraviolet rays can be exemplified, but also medicinal ingredients, physiologically active ingredients or pharmacologically active ingredients can be exemplified. As such active ingredients, examples include: local anesthetic ingredients (lidocaine, dibucaine hydrochloride, dibucaine, benzocaine, etc.), analgesic ingredients (salicylic acid derivatives such as methyl salicylate, indomethacin, piroxicam, ketoprofen, felbinac, etc.), anti-inflammatory ingredients (glycyrrhizic acid, glycyrrhizic acid dipotassium salts; glycyrrhetic acid, stearyl glycyrrhetinate, butylbenzyl hydroxy acid, benzyl nicotinate, hydrocortisone, hydrocortisone butyrate, hydrocortisone acetate, prednisone valerate acetate (prednisone valerate acetate, etc.) valeroacetate), prednisone acetate, prednisone, dexamethasone, dexamethasone acetate, dimethyl isopropyl azulene picroprofen, arnica extract, scutellaria baicalensis extract, cattail extract, chamomile extract, calamine, licorice extract, guaiac oil, gardenia extract, gentian extract, black tea extract, tocopherol, tocopheryl acetate, comfrey extract, perilla extract, peony extract, sage extract, swertia japonica extract, morus alba bark extract, pyridoxine hydrochloride, peach leaf extract, cornflower extract, saxifrage extract, mugwort extract, Roman chamomile extract, etc.), antihistamine ingredients (chlorpheniramine maleate, diphenhydramine, diphenhydramine hydrochloride, diphenhydramine salicylate, etc.), local irritant ingredients (ammonia, l-menthol, dl-camphor hor), peppermint oil, benzyl nicotinate, valyl nonylamide, etc.), antipruritic ingredients (crotamiton, etc.), antiseptic or bactericidal ingredients (acrinol, chlorhexidine gluconate, chlorhexidine hydrochloride, benzalkonium chloride, benzethonium chloride, povidone iodine, iodoform, iodine, potassium iodide, mercurochrome, cresol, triclosan, phenol, isopropyl cresol, thymol, sodium salicylate, undecylenic acid, photosensitizer, hinokitiol, phenoxyethanol, chlorobutanol, quaternary ammonium salt 73, zinc pyrithione, parabens, eucalyptus extract, raprosin rosemary, etc.), antifungal ingredients (clotrimazole, clotrimazole acetate, miconazole acetate, econazole acetate, bifonazole, oxoconazole acetate, sulconazole acetate, neticonazole hydrochloride, bifonazole and tioconazole, omoconazole acetate, etc. imidazole antifungal agents; terbinafine, terbinafine hydrochloride and allylamine antifungals such as naftifine; benzylamine antifungals such as butenafine; allylamine antifungals such as apomorphine hydrochloride; thiocarbamic acid antifungals such as tolnaftate and tolcylcerate; nitropyrrolidone, isazolam, ciclopirox, etc.) tissue repair ingredients (allantoin, heparin analogs, vitamin A palmitate, vitamin D2, retinyl acetate, retinol, vitamin A oil, panthenol, etc.), astringent ingredients (zinc oxide, acanthopanax senticosus extract, aluminum chloride, yellow cucurbit extract and its salts, citric acid, birch extract, tea extract, hops extract, horse chestnut extract, etc.), dead skin toughening ingredients (urea, glycerin, concentrated glycerin, potassium hydroxide, salicylic acid, sulfur, colloidal sulfur, resorcinol, glycolic acid, lactic acid, sodium sulfate, etc.), moisturizing ingredients (butylene glycol, sodium pyrrolidone carboxylate, propylene glycol , sodium salt of nucleic acid, angelica dahurica leaf extract, aspartic acid, alanine, arginine, sodium alginate, marshmallow extract, aloe vera extract, oyster extract, hydrolyzed keratin, hydrolyzed collagen, hydrolyzed conchiolin, hydrolyzed eggshell membrane, hydrolyzed egg white, hydrolyzed silk, brown algae extract, quince extract, blackberry bush extract, xylitol, keto acid, cucumber extract, quince seed extract, glycine, glycerin, glucose, cape aloe extract, cystine, cysteine, mallow extract, serine, sorbitol, trehalulose, sodium lactate, sodium hyaluronate, placenta extract, loofah extract, reduced maltose, mannitol, lily extract, lactoferrin, lysine, apple extract, royal jelly extract, etc.), emollient ingredients (almond oil, avocado oil, olive oil, oleic acid, Atlantic bream oil (orange) roughyoil), cocoa butter, carrot extract, squalene, ceramide, evening primrose oil, grape seed oil, jojoba oil, macadamia nut oil, mineral oil, mink oil, eucalyptus oil, rosehip oil, petrolatum, etc.), whitening ingredients (ascorbic acid, ascorbic acid derivatives, arbutin, retinol (recinol), ellagic acid, glutathione, kojic acid, rosehip extract, kiwi extract, etc.), UV protection ingredients (para-aminobenzoic acid, ethyl para-aminobenzoate, glyceryl para-aminobenzoate, para-dimethylaminobenzoate The present invention also includes, but is not limited to, herbal extract ingredients, vitamins, amino acids or minerals, etc., including, but not limited to, amyl formate, 2-ethylhexyl p-dimethylaminobenzoate, tert-butyl methoxydibenzoylmethane, oxybenzones, octyl triazone, octyl salicylate, ethyl diisopropyl cinnamate, methyl diisopropyl cinnamate, cinnamon ether ester, dimethoxycinnamic acid glyceryl caprylate, octyl dimethoxybenzylidene dioxoimidazolidine propionate, tea extract, drometrizole, isopropyl p-methoxycinnamate, homosalate, octyl methoxycinnamate, etc.
上述皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物根据用途可包含其他的溶剂、溶剂或添加剂等。The above-mentioned external skin preparation composition, cosmetic composition, or mascara composition may contain other solvents, solvents, additives, etc. depending on the application.
上述中,作为溶剂或溶剂成分,根据组合物的用途、使用形态等,例如可例示出:醇(例如,聚乙二醇等)、醚(除乙醚等以外,还有乙二醇醚类(甲基溶纤剂等溶纤剂类;二乙二醇二乙醚等的二亚烷基二醇烷基醚类等)等)、腈(乙腈等)、酮(丙酮等)或酯(乙酸乙酯等羧酸烷基酯等)等。In the above, examples of the solvent or solvent component include alcohols (e.g., polyethylene glycol), ethers (in addition to ethyl ether, glycol ethers (cellosolves such as methyl cellosolve; dialkylene glycol alkyl ethers such as diethylene glycol diethyl ether), nitriles (acetonitrile), ketones (acetone), and esters (carboxylic acid alkyl esters such as ethyl acetate).
另外,作为添加剂,不仅可例示出增塑剂、湿润剂、消泡剂、着色剂、防腐剂、芳香剂、调味剂、颜料或增稠剂等,还可例示出在准药品、医药用品或化妆品等中使用的常用成分,例如粉末状基质或载体(粘结剂、崩解剂、赋形剂或润滑剂等)、油性基质或载体(动植物油、凡士林、石蜡油、硅油、高级脂肪酸酯或高级脂肪酸等)、水性基质或载体(黄原胶等凝胶基质等)、防腐剂、螯合剂、抗氧化剂、清新剂、稳定剂、流化剂、乳化剂、增稠剂、缓冲剂、分散剂、吸附剂、保湿剂、湿润剂、干燥剂、抗静电剂或其他树脂(聚酰胺系树脂、氢化聚丁烯等烯烃系树脂等)等,但不限于此。Examples of additives include, but are not limited to, plasticizers, wetting agents, defoaming agents, colorants, preservatives, fragrances, flavorings, pigments, and thickeners, and also include common ingredients used in quasi-drugs, pharmaceuticals, and cosmetics, such as powdered bases or carriers (binders, disintegrants, excipients, and lubricants), oily bases or carriers (animal and vegetable oils, petrolatum, paraffin oil, silicone oil, higher fatty acid esters or higher fatty acids), aqueous bases or carriers (gel bases such as xanthan gum), preservatives, chelating agents, antioxidants, fresheners, stabilizers, fluidizers, emulsifiers, thickeners, buffers, dispersants, adsorbents, moisturizers, wetting agents, desiccants, antistatic agents, and other resins (polyamide resins, olefin resins such as hydrogenated polybutene, etc.).
对使用如上述的成分或必要时追加其他公知的成分来制备上述皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物等的方式没有特别限制,可使用公知的方式。There are no particular limitations on the method for preparing the above-mentioned external skin preparation composition, cosmetic composition, mascara composition, etc. using the above-mentioned components or, if necessary, adding other known components, and a known method can be used.
发明效果Effects of the Invention
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
本申请能够提供皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物,其使用了对极性和非极性溶剂表现出低溶解度、对上述溶剂具有低扩散特性的、适合成膜的功能高分子。使用上述高分子的组合物能够对如皮脂、汗液和泪液等多种溶剂显示出耐性,从而能够有效地保持化妆等的持续性。The present application provides a composition for external use on skin, a cosmetic composition, or a mascara composition that utilizes a functional polymer suitable for film formation, exhibiting low solubility in polar and non-polar solvents, low diffusion properties in these solvents. Compositions utilizing such polymers exhibit resistance to various solvents, such as sebum, sweat, and tears, thereby effectively maintaining the long-lasting application of makeup.
具体实施方式DETAILED DESCRIPTION
下面,通过实施例和比较例具体地说明本申请,但本申请的范围不限于下述实施例。Hereinafter, the present application will be specifically described with reference to Examples and Comparative Examples, but the scope of the present application is not limited to the following Examples.
下述实施例和比较例中,以下述方式评价各物性。In the following Examples and Comparative Examples, various physical properties were evaluated in the following manner.
1.高分子的溶解度测定1. Solubility determination of polymers
将实施例或比较例中制得的高分子溶液在约150℃的温度下保持约60分钟,使溶剂挥发。提取使溶剂挥发的1g高分子。将提取的1g高分子放入溶剂(己烷、乙酸乙酯、丙酮或水)5g中,在常温下搅拌30分钟,然后去除不溶解的残留高分子。将去除了残留高分子的透明溶液分馏,在150℃下干燥30分钟而去除溶剂。通过对去除了溶剂的溶液中所残留的高分子的质量进行比较,计算固体成分含量。通过固体成分含量来测定溶解于溶剂内的高分子的浓度,将该测得的量换算成相对于100g的溶剂的数值来求出溶解度。对于在去除残留高分子之后溶液也不透明的情况,使溶液通过过滤器(0.45μm,NYLON)而得到透明溶液之后,执行上述过程。The polymer solution prepared in the embodiment or comparative example is kept at a temperature of about 150°C for about 60 minutes to evaporate the solvent. 1g of the polymer from which the solvent is evaporated is extracted. 1g of the extracted polymer is placed in 5g of a solvent (hexane, ethyl acetate, acetone or water), stirred at room temperature for 30 minutes, and then the insoluble residual polymer is removed. The transparent solution from which the residual polymer has been removed is fractionated and dried at 150°C for 30 minutes to remove the solvent. The solid content is calculated by comparing the mass of the residual polymer in the solution from which the solvent has been removed. The concentration of the polymer dissolved in the solvent is determined by the solid content, and the measured amount is converted into a value relative to 100g of solvent to determine the solubility. In the case where the solution is not transparent even after removing the residual polymer, the above process is performed after the solution is passed through a filter (0.45μm, NYLON) to obtain a transparent solution.
<溶解度评价标准><Solubility Evaluation Criteria>
A:溶解度为15以上的情况A: When the solubility is 15 or more
B:溶解度大于10且小于15的情况B: Solubility greater than 10 and less than 15
C:溶解度大于5且为10以下的情况C: When the solubility is greater than 5 and less than 10
D:溶解度为5以下的情况D: When the solubility is 5 or less
2.分子量测定2. Molecular Weight Determination
使用GPC以下面的条件测定重均分子量(Mw)和分子量分布(PDI),在校准曲线的制作中使用Agilent系统的标准聚苯乙烯来换算测定结果。The weight average molecular weight (Mw) and molecular weight distribution (PDI) were measured using GPC under the following conditions, and the measurement results were converted using standard polystyrene of an Agilent system to prepare a calibration curve.
<测定条件><Measurement conditions>
测量仪:Agilent GPC(Agilent1200系列,U.S.)Measuring instrument: Agilent GPC (Agilent 1200 series, U.S.)
柱:连接有2个PL Mixed BColumn: Connected with 2 PL Mixed B
柱温:40℃Column temperature: 40°C
洗脱液:THF(四氢呋喃)Eluent: THF (tetrahydrofuran)
流速:1.0mL/分钟Flow rate: 1.0 mL/min
浓度:~1mg/mL(注入100μL)Concentration: ~1 mg/mL (inject 100 μL)
3.玻璃化转变温度的计算3. Calculation of glass transition temperature
根据单体组成并通过下述数值公式算出玻璃化转变温度(Tg)。The glass transition temperature (Tg) was calculated from the monomer composition using the following numerical formula.
<数值公式><Numerical formula>
1/Tg=ΣWn/Tn1/Tg=ΣWn/Tn
上述数值公式中,Wn为高分子的各单体的重量分数,Tn为单体形成均聚物的高分子的情况下显示的玻璃化转变温度,上述数值公式的右边是将所使用的单体的重量分数除以该单体形成均聚物的高分子的情况下显示的玻璃化转变温度的数值(Wn/Tn)按不同的单体进行计算之后,对所有计算的数值求和的结果。In the above numerical formula, Wn is the weight fraction of each monomer in the polymer, Tn is the glass transition temperature displayed when the monomer forms a homopolymer of the polymer, and the right side of the above numerical formula is the weight fraction of the monomer used divided by the glass transition temperature displayed when the monomer forms a homopolymer of the polymer (Wn/Tn), calculated for each monomer, and the result of summing all the calculated values.
4.皮脂扩散试验4. Sebum diffusion test
将各制备例中制得的高分子以约10重量%的浓度溶解于作为溶剂的异十二烷(isododecane)中,并且使地蜡(ceresine)、合成蜡(synthetic wax)和氧化微晶醋(microcrystanlline wax)分别以7重量%、6重量%和8重量%的浓度在约90℃的温度下溶解而制备组合物A。接着,在上述组合物A中分别以8重量%和2重量%的浓度追加碳酸丙烯酯(propylene carbonate)和二硬脂二甲铵锂蒙脱石(disteardimonium hectorite),均匀地分散20分钟来制备组合物B。接着,将氧化铁(iron oxide(CI 77499))以6重量%的浓度追加到上述中之后,适量添加保存剂(preservatives),分散30分钟之后,缓慢冷却至约28℃左右,从而制备睫毛膏剂型。The polymer prepared in each preparation example was dissolved in isododecane as a solvent at a concentration of approximately 10% by weight. Ceresine, synthetic wax, and microcrystalline wax were dissolved at concentrations of 7%, 6%, and 8% by weight, respectively, at approximately 90°C to prepare Composition A. Propylene carbonate and disteardimonium hectorite were then added to Composition A at concentrations of 8% and 2% by weight, respectively, and uniformly dispersed for 20 minutes to prepare Composition B. Iron oxide (CI 77499) was then added to the mixture at a concentration of 6% by weight. An appropriate amount of preservative was then added, the mixture was dispersed for 30 minutes, and then slowly cooled to approximately 28°C to prepare a mascara formulation.
使用制得的睫毛膏剂型的皮脂扩散试验分为体外试验和体内试验来进行,具体内容如下。The sebum diffusion test using the prepared mascara formulation was conducted in both in vitro and in vivo tests, as detailed below.
体外试验In vitro tests
将睫毛膏剂型以30μm厚度涂布于玻璃片(玻璃板)上,然后在室温下完全干燥。干燥后,向睫毛膏分别滴加0.1g水和皮脂,放置20分钟之后,将化妆棉置于其上,并以200gf的力往返运动30次之后,对渗出化妆棉的程度进行比较,并根据下述标准进行评价。The mascara formulation was applied to a glass sheet (glass plate) at a thickness of 30 μm and then completely dried at room temperature. After drying, 0.1 g of water and sebum were added dropwise to the mascara. After 20 minutes, a cotton pad was placed on the mascara and moved back and forth 30 times with a force of 200 gf. The degree of seepage from the cotton pad was compared and evaluated according to the following criteria.
<评价标准><Evaluation Criteria>
根据渗出化妆棉的程度,以0至5的范围内的尺度进行比较时,将睫毛膏完全没有渗出化妆棉的情况设为5,将使用下述比较例1的高分子的情况作为对照组(reference)设为3,并将相对于上述对照组为优秀的等级作为试样间的相对对照数值化至小数点首位。The degree of bleeding from the cotton pad was compared on a scale of 0 to 5, with a value of 5 being given for a case where the mascara did not bleed from the cotton pad at all, and a value of 3 being given for a control (reference) using the polymer of Comparative Example 1 below. The grade that was excellent compared to the control was numerically expressed to the first decimal place as a relative comparison between the samples.
体内试验:In vivo testing:
将制得的睫毛膏剂型涂布于被试验者的眼睫毛上6小时之后,拍摄图像进行比较,并根据下述标准进行评价。Six hours after applying the prepared mascara formulation to the eyelashes of the subjects, images were taken for comparison and evaluation based on the following criteria.
<评价标准><Evaluation Criteria>
经过6小时后,拍摄图像,对扩散面积进行图像分析,从而表示为数值。在图像分析时,将扩散的面积以像素(pixel)单位进行数值化来表示。After 6 hours, an image was taken and the diffusion area was analyzed and expressed as a numerical value. In the image analysis, the diffusion area was expressed as a numerical value in pixel units.
5.耐水性试验5. Water resistance test
将上述制得的睫毛膏剂型以30μm的厚度涂布于玻璃片(玻璃板)上,然后在室温下使其完全干燥,将干燥的试样在常温下在水中浸渍约30分钟之后,取出并根据质量减少率(=100×(1-B/A),单位:%,上述A为涂布了睫毛膏剂型的玻璃片的总质量,B为将上述在水中浸渍之后,取出并去除湿气之后测定的玻璃片的总质量。)、按照下述标准评价耐水性。The mascara formulation prepared above was applied to a glass sheet (glass plate) at a thickness of 30 μm and then completely dried at room temperature. The dried sample was then immersed in water at room temperature for approximately 30 minutes, removed, and water resistance was evaluated according to the following criteria based on the mass loss rate (=100×(1-B/A), unit: %), where A is the total mass of the glass sheet coated with the mascara formulation, and B is the total mass of the glass sheet measured after immersion in water, removal, and dehumidification.
<评价标准><Evaluation Criteria>
A:质量减少率为5%以下的情况A: When the mass reduction rate is 5% or less
B:质量减少率大于5%的情况B: Mass reduction rate greater than 5%
6.NMR评价方法6.NMR evaluation method
提取0.1g实施例或比较例中制得的高分子溶液,溶解于下述NMR用溶剂1mL中,使用下述分析仪器并根据制备商的手册来测定1H-NMR,由此能够确认高分子的成分和转换率。例如,在存在未聚合的单体的情况下,在H-NMR光谱中的约5.7ppm至6.4ppm附近确认到来自双键末端的=CH2的-H峰,通过来自各高分子结构中的-H峰的面积能够确认制得的高分子的成分。0.1 g of the polymer solution prepared in the Examples or Comparative Examples was extracted and dissolved in 1 mL of the following NMR solvent. 1H-NMR was measured using the following analyzer according to the manufacturer's manual to confirm the composition and conversion rate of the polymer. For example, in the presence of unpolymerized monomer, a -H peak originating from =CH2 at the end of the double bond was observed in the H-NMR spectrum at approximately 5.7 ppm to 6.4 ppm. The composition of the resulting polymer can be confirmed by the area of the -H peak originating from each polymer structure.
<测定条件><Measurement conditions>
分析仪器:500MHz NMR(Varian Unity Inova 500),1H-NMRAnalytical instruments: 500 MHz NMR (Varian Unity Inova 500), 1H-NMR
浓度:10至20mg/mL,溶剂:CDCl3-d3(氘代三氯甲烷)Concentration: 10 to 20 mg/mL, solvent: CDCl3-d3 (deuterated chloroform)
温度:25℃Temperature: 25℃
实施例1Example 1
如下表1所示,将EHMA(甲基丙烯酸2-乙基己酯(ethylhexyl methacrylate))、IBOMA(甲基丙烯酸异冰片酯(isobornyl methacrylate))及EOEOEA(乙氧基乙氧基乙基丙烯酸酯(ethoxyethoxyethyl acrylate))以25:60:15的重量比率(EHMA:IBOMA:EOEOEA)混合而得到单体混合物,将该单体混合物以总单体的浓度为约35重量%的方式投入到作为溶剂的异十二烷(Isododecane)中,接着,在搅拌的同时,在常温下用氮气进行鼓泡约30分钟,从而去除溶解氧。将去除氧的反应混合物升温至70℃左右的温度,并且进一步进行约40分钟的氮气鼓泡。通过上述过程,温度升高至70℃时,进一步将适量的热引发剂(V-65,WakoChemicals)投入并溶解于作为溶剂的异十二烷中,并使之进行聚合反应。在进行约24小时左右反应之后,将温度降低至常温使其终止,并获得高分子溶液。As shown in Table 1 below, a monomer mixture was prepared by mixing EHMA (2-ethylhexyl methacrylate), IBOMA (isobornyl methacrylate), and EOEOEA (ethoxyethoxyethyl acrylate) at a weight ratio of 25:60:15 (EHMA:IBOMA:EOEOEA). This monomer mixture was added to isododecane as a solvent to a total monomer concentration of approximately 35% by weight. Subsequently, the mixture was sparged with nitrogen for approximately 30 minutes at room temperature while stirring to remove dissolved oxygen. The deoxygenated reaction mixture was heated to approximately 70°C and sparged with nitrogen for approximately 40 minutes. When the temperature reached 70°C, an appropriate amount of a thermal initiator (V-65, Wako Chemicals) was added and dissolved in the isododecane solvent, and a polymerization reaction was carried out. After the reaction was allowed to proceed for about 24 hours, the temperature was lowered to room temperature to terminate the reaction and obtain a polymer solution.
实施例2至10以及比较例1和2Examples 2 to 10 and Comparative Examples 1 and 2
将单体混合物的单体的种类和比率如下表1和2所示改变,除此以外,以如实施例1所述的方式获得高分子溶液。A polymer solution was obtained in the same manner as in Example 1 except that the types and ratios of the monomers in the monomer mixture were changed as shown in Tables 1 and 2 below.
表1Table 1
表2Table 2
1.NMR评价1. NMR evaluation
对实施例1的高分子进行NMR评价,结果几乎没有确认到来自单体的双键末端的=CH2的1H峰,由此能够确认形成了有效的聚合。另外,在5.0ppm至3.5ppm区域观察到与形成高分子的EHMA和IBOMA的-COO-相邻的-CH-峰以及来自EOEOEA的-OCH2CH2O-的峰,此时,峰的面积值为9。另外,来自侧链的-CH2-和间位的-CH3的峰在2.5ppm至1.3ppm区域,被确认为面积值为36的峰,从高分子主链的-CH2CH-或-CH2CH2确认到的1H的峰的面积在1.3ppm至0.5ppm区域被确认为55。NMR evaluation of the polymer of Example 1 revealed almost no 1H peaks derived from the double bond terminals of the monomers, confirming effective polymerization. Furthermore, a -CH- peak adjacent to -COO- of EHMA and IBOMA forming the polymer, as well as a peak derived from -OCH2CH2O- of EOEOEA, were observed in the 5.0 ppm to 3.5 ppm region, with an area value of 9. Furthermore, peaks derived from -CH2- and -CH3 at the meta position of the side chain were observed in the 2.5 ppm to 1.3 ppm region, with an area value of 36. The 1H peak derived from -CH2CH- or -CH2CH2 in the polymer main chain was observed in the 1.3 ppm to 0.5 ppm region, with an area value of 55.
对实施例2的高分子也同样地评价NMR。评价结果,几乎没有确认到来自双键末端的=CH2的1H峰,由此能够确认有效地进行了聚合。另外,与形成高分子的EHA和CHMA的-COO-相邻的-CH-峰以及来自EOEOEA的-OCH2CH2O的峰在4.8ppm至3.4ppm区域,被确认为面积值为10。另外,从与形成高分子的EHA的-COO-相邻的-CH2-,在2.5ppm至2.0ppm区域确认到面积值约3左右的峰,从侧链的-CH2-和间位的-CH3在2.0ppm至1.5ppm区域,确认到面积值为57的峰。另外,从高分子主链的-CH2CH-或-CH2CH2-确认到的1H面积值在1.5ppm至0.5ppm为约29。The polymer of Example 2 was also evaluated by NMR in the same manner. As a result of the evaluation, almost no 1H peak of =CH2 from the double bond terminal was confirmed, which confirmed that polymerization was carried out effectively. In addition, the -CH- peak adjacent to -COO- of EHA and CHMA forming the polymer and the peak of -OCH2CH2O from EOEOEA were confirmed to have an area value of 10 in the region of 4.8ppm to 3.4ppm. In addition, a peak with an area value of about 3 was confirmed in the region of 2.5ppm to 2.0ppm from -CH2- adjacent to -COO- of EHA forming the polymer, and a peak with an area value of 57 was confirmed in the region of 2.0ppm to 1.5ppm from -CH2- of the side chain and -CH3 at the meta position. In addition, the 1H area value confirmed from -CH2CH- or -CH2CH2- of the polymer main chain was about 29 in the region of 1.5ppm to 0.5ppm.
在实施例3的高分子的情况下,也几乎没有确认到来自双键末端的=CH2的1H峰。另外,与形成高分子的LMA和IBOMA的-COO-相邻的-CH2-和-CH-峰以及来自PEGMA的-OCH2CH2-O和-OCH3的峰出现在4.7ppm至3.3ppm区域,其峰的面积值为17。另外,来自侧链的-CH2-和间位的-CH3的峰的面积值在2.0ppm至1.5ppm区域被确认为72,从高分子主链的-CH2CH-确认到的1H峰的面积值在约1.5ppm至0.5ppm区域为11。In the case of the polymer of Example 3, almost no 1H peaks were observed for =CH2 at the double bond terminals. Furthermore, the -CH2- and -CH- peaks adjacent to -COO- of LMA and IBOMA, which form the polymer, and the -OCH2CH2-O and -OCH3 peaks derived from PEGMA appeared in the 4.7-3.3 ppm region, with an area value of 17. Furthermore, the peaks derived from -CH2- and -CH3 at the meta position of the side chains had an area value of 72 in the 2.0-1.5 ppm region, and the 1H peak derived from -CH2CH- in the polymer backbone had an area value of 11 in the approximately 1.5-0.5 ppm region.
在对实施例4的高分子的NMR测定结果中,也几乎没有观察到来自双键末端的=CH2的1H峰。另外,与形成高分子的LMA和IBOMA的-COO-相邻的-CH2-和-CH-峰以及来自EOEOEA的-OCH2CH2O-的峰出现在4.7ppm至3.3ppm区域,峰的面积值为9。另外,从来自侧链的-CH2-和间位的-CH3在2.0ppm至1.5ppm区域,确认到面积值为36的峰,并从高分子主链的-CH2CH-或-CH2CH2-确认到的1H面积值在1.5ppm至0.5ppm为55。In the NMR measurements of the polymer of Example 4, almost no 1H peaks were observed for =CH2 at the double bond terminals. Furthermore, the -CH2- and -CH- peaks adjacent to -COO- in LMA and IBOMA, which form the polymer, and the -OCH2CH2O- peak from EOEOEA appeared in the 4.7 ppm to 3.3 ppm region, with peak areas of 9. Furthermore, peaks with an area of 36 were observed in the 2.0 ppm to 1.5 ppm region from -CH2- and -CH3 at the meta position of the side chains, and a 1H peak with an area of 55 was observed from -CH2CH- or -CH2CH2- in the polymer main chain in the 1.5 ppm to 0.5 ppm region.
对实施例5的高分子进行NMR分析,结果几乎没有确认到来自双键末端的=CH2的1H峰,由此可知有效地进行了聚合。另外,与用于形成高分子的单体的LMA、IBOMA和KBE-503的-COO-相邻的-CH2-和-CH-峰、来自EOEOEA的-OCH2CH2O-峰以及来自KBE-503的SiO(CH2-)3的峰在4.7ppm至3.3ppm区域,被确认为面积值为10。来自侧链的-CH2-和间位的-CH3的峰在2.0ppm至1.5ppm区域,被确认为面积值为35,且来自高分子主链的-CH2CH-或-CH2CH2-的1H峰在1.5ppm至0.5ppm,被确认为面积值为55。NMR analysis of the polymer in Example 5 revealed virtually no 1H peaks originating from the double bond terminals, indicating efficient polymerization. Furthermore, -CH2- and -CH- peaks adjacent to -COO- of the polymer-forming monomers LMA, IBOMA, and KBE-503, the -OCH2CH2O- peak derived from EOEOEA, and the SiO(CH2-)3 peak derived from KBE-503 were observed in the 4.7 to 3.3 ppm region, with an area value of 10. Peaks from the -CH2- and meta-positions of the side chains were observed in the 2.0 to 1.5 ppm region, with an area value of 35. Furthermore, 1H peaks from -CH2CH- or -CH2CH2- in the polymer backbone were observed in the 1.5 to 0.5 ppm region, with an area value of 55.
在实施例6的情况下,进行NMR评价,结果也几乎没有确认到来自双键末端的=CH2的1H峰。与用于形成高分子的EHMA、IBOMA和KBM-503的-COO-相邻的-CH-峰、来自EOEOEA的-OCH2CH2O-的峰、来自KBM-503的-Si-O(CH3)3的峰在5.0ppm至3.5ppm区域,被确认为面积值为9。另外,从侧链的-CH2-和间位的-CH3在2.5ppm至1.3ppm区域,确认到面积值为36的峰,从高分子主链的-CH2CH-或-CH2CH2-确认到的1H面积值在1.3ppm至0.5ppm区域为55。In Example 6, NMR analysis revealed that almost no 1H peaks were observed for =CH2 at the double bond terminals. A peak for -CH- adjacent to -COO- in EHMA, IBOMA, and KBM-503, the polymer-forming compounds, a peak for -OCH2CH2O- in EOEOEA, and a peak for -Si-O(CH3)3 in KBM-503 were observed in the 5.0-3.5 ppm region, with an area value of 9. Furthermore, peaks with an area value of 36 were observed in the 2.5-1.3 ppm region from -CH2- and -CH3 at the meta position in the side chains, and a 1H peak with an area value of 55 was observed in the 1.3-0.5 ppm region from -CH2CH- or -CH2CH2- in the polymer backbone.
在实施例7的高分子的情况下,以根据1H-NMR评价方法的步骤进行分析,结果,几乎没有确认到来自双键末端的=CH2的1H峰。与形成高分子的LMA、IBOMA和KBE-503的-COO-相邻的-CH2-和-CH-峰、EOEOEA的-OCH2CH2O-峰、以及来自KBE-503的-SiO(CH2-)3的峰在4.7ppm至3.3ppm区域,被确认为面积值为11。从侧链的-CH2-和间位的-CH3在2.0ppm至1.5ppm区域,确认到面积值为35的峰,从高分子主链的-CH2CH-或-CH2CH2-确认到的1H面积值在1.5ppm至0.5ppm为55。Analysis of the polymer in Example 7 using the 1H-NMR evaluation method revealed virtually no 1H peaks originating from the terminal =CH2 double bonds. The -CH2- and -CH- peaks adjacent to -COO- of LMA, IBOMA, and KBE-503, the -OCH2CH2O- peak of EOEOEA, and the -SiO(CH2-)3 peak derived from KBE-503 were observed in the 4.7-3.3 ppm region, with an area value of 11. Peaks with an area value of 35 were observed in the 2.0-1.5 ppm region from the -CH2- and meta-positions of the side chains, and 55 from the 1H area value of -CH2CH- or -CH2CH2- in the polymer backbone, from 1.5-0.5 ppm.
对实施例8的高分子进行NMR评价,结果可知,没确认到来自双键末端的=CH2的1H峰,由此能够确认有效地进行了聚合。另外,与形成高分子的LMA和IBOMA的-COO-相邻的-CH2-和-CH-峰以及来自PEGMA的-OCH2CH2-O和-OCH3的峰在5.0ppm至2.8ppm区域,被确认为面积值为14。还确认到VA的-COO-CH3峰、从侧链的-CH2-和间位的-CH3在2.0ppm至1.5ppm区域面积值为35的峰,从高分子主链的-CH2CH-和-CH2CH2-确认到的1H面积值在1.5ppm至0.5ppm为51。NMR analysis of the polymer in Example 8 revealed no 1H peaks derived from the =CH2 residue at the double bond terminals, confirming efficient polymerization. Furthermore, peaks of -CH2- and -CH- adjacent to -COO- residues of LMA and IBOMA constituting the polymer, as well as peaks derived from -OCH2CH2-O and -OCH3 residues of PEGMA, were observed in the 5.0 to 2.8 ppm region, with an area value of 14. Furthermore, a -COO-CH3 peak of VA was observed, as well as peaks derived from -CH2- and -CH3 residues in the side chains in the meta position, with an area value of 35 in the 2.0 to 1.5 ppm region. 1H peaks derived from -CH2CH- and -CH2CH2- residues in the polymer backbone had an area value of 51 in the 1.5 to 0.5 ppm region.
在实施例9的高分子的情况下,也几乎没有确认到来自双键末端的=CH2的1H峰,与EHMA和IBOMA的-COO-相邻的-CH-峰、PEGMA的-OCH2CH2-O和-OCH3峰、来自NVP的-NCH2-的峰出现在5.0ppm至2.8ppm区域,且峰的面积值为9。另外,从侧链的-CH2-和间位的-CH3在2.5ppm至1.5ppm区域,确认到面积值为37的峰,从高分子主链的-CH2CH-和-CH2CH2-确认到的1H面积值在1.5ppm至0.5ppm为54。In the case of the polymer of Example 9, almost no 1H peaks were observed for =CH2 at the double bond terminals. The -CH- peaks adjacent to -COO- of EHMA and IBOMA, the -OCH2CH2-O and -OCH3 peaks of PEGMA, and the -NCH2- peak derived from NVP appeared in the 5.0 ppm to 2.8 ppm region, with a peak area value of 9. Furthermore, peaks with an area value of 37 were observed in the 2.5 ppm to 1.5 ppm region from -CH2- and -CH3 at the meta position of the side chain, and the 1H area value of 54 was observed from -CH2CH- and -CH2CH2- in the polymer main chain in the 1.5 ppm to 0.5 ppm region.
在实施例10的情况下,未观察到来自双键末端的=CH2的1H峰,与形成高分子的EHMA和IBOMA的-COO-相邻的-CH-峰、PEGMA的-OCH2CH2-O和-OCH3峰、来自NVP的-NCH2-的峰在5.0ppm至2.8ppm区域,被确认为面积值为11。另外,从侧链的-CH2-和间位的-CH3在2.5ppm至1.5ppm区域,确认到面积值为37的峰,从高分子主链的-CH2CH-和-CH2CH2-确认到的1H面积值在1.5-0.5ppm为52。In the case of Example 10, no 1H peak originating from =CH2 at the double bond terminal was observed. However, the -CH- peak adjacent to -COO- of EHMA and IBOMA constituting the polymer, the -OCH2CH2-O and -OCH3 peaks of PEGMA, and the -NCH2- peak originating from NVP were confirmed in the 5.0 ppm to 2.8 ppm region with an area value of 11. Furthermore, peaks with an area value of 37 were confirmed in the 2.5 ppm to 1.5 ppm region from -CH2- and -CH3 at the meta position of the side chain, and the 1H peaks from -CH2CH- and -CH2CH2- in the polymer main chain had an area value of 52 in the 1.5-0.5 ppm region.
2.物性评价2. Physical property evaluation
将对实施例和比较例的各高分子测定物性的结果整理并记载于下表3和4。The results of measuring the physical properties of each polymer in Examples and Comparative Examples are summarized and described in Tables 3 and 4 below.
表3Table 3
表4Table 4
从上述结果能够确认本申请所使用的高分子对极性和非极性溶剂表现出低溶解度,为对上述溶剂具有低扩散特性的适合成膜的高分子,由此能够确认,由于能够对如皮脂、汗液和泪液等多种溶剂显示出耐性,从而能够提供能够有效地保持化妆等的持续性的皮肤外用剂组合物、化妆材料组合物或睫毛膏组合物。The above results confirm that the polymer used in the present application has low solubility in polar and non-polar solvents and is a polymer suitable for film formation having low diffusion properties in these solvents. Therefore, it can be confirmed that the polymer exhibits resistance to various solvents such as sebum, sweat, and tears, thereby providing a skin external application composition, cosmetic material composition, or mascara composition that can effectively maintain the durability of makeup, etc.
Claims (14)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2014-0180731 | 2014-12-15 | ||
| KR10-2014-0180734 | 2014-12-15 | ||
| KR10-2014-0180732 | 2014-12-15 | ||
| KR10-2014-0180733 | 2014-12-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1235010A1 HK1235010A1 (en) | 2018-03-02 |
| HK1235010B true HK1235010B (en) | 2021-10-22 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3235838B1 (en) | Polymer | |
| JP6771524B2 (en) | High molecular | |
| CN106999404B (en) | Skin external preparation composition | |
| CN106999403B (en) | Skin external preparation composition | |
| HK1235010B (en) | Topical composition for skin | |
| CN106604942B (en) | polymer | |
| EP3225640B1 (en) | Polymer | |
| KR101773681B1 (en) | Skin external preparation composition | |
| JP7657566B2 (en) | Polymer Composition | |
| HK1235010A1 (en) | Topical composition for skin | |
| HK1235273B (en) | Topical composition for skin | |
| KR101773684B1 (en) | Skin external preparation composition | |
| HK1235273A1 (en) | Topical composition for skin |